5′/ 3′ imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer
Abstract Background Detecting an ALK fusion gene in patients with non-small cell lung cancer (NSCLC) could provide evidence to guide individualized therapy. Methods The 5′/3′ imbalance strategy for quantitative reverse transcription-PCR (RT-qPCR) was developed to detect ALK fusion genes in circulati...
Main Authors: | Yongqing Tong, Zhijun Zhao, Bei Liu, Anyu Bao, Hongyun Zheng, Jian Gu, Mary McGrath, Ying Xia, Bihua Tan, Chunhua Song, Yan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-018-0735-1 |
Similar Items
-
Detection of ALK fusion transcripts in FFPE lung cancer samples by NanoString technology
by: Adriane F. Evangelista, et al.
Published: (2017-05-01) -
Novel NLRC4‐ALK and EML4‐ALK double fusion mutations in a lung adenocarcinoma patient: A case report
by: Xueqian Wu, et al.
Published: (2020-06-01) -
ALK-positive histiocytosis of the umbilicus with KIF5B-ALK fusion: A case report and review of the literature
by: Yili Zhu, et al.
Published: (2021-06-01) -
Catalog of 5’ Fusion Partners in ALK-positive NSCLC Circa 2020
by: Sai-Hong Ignatius Ou, MD, PhD, et al.
Published: (2020-03-01) -
Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer
by: Jin Kang, et al.
Published: (2020-12-01)